Comments
Loading...

Kura Oncology Analyst Ratings

KURANASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$10.00
Consensus Price Target1
$25.17

Kura Oncology Analyst Ratings and Price Targets | NASDAQ:KURA | Benzinga

Kura Oncology Inc has a consensus price target of $25.17 based on the ratings of 14 analysts. The high is $40 issued by HC Wainwright & Co. on April 28, 2025. The low is $10 issued by Scotiabank on January 8, 2025. The 3 most-recent analyst ratings were released by Mizuho, Barclays, and JMP Securities on May 19, 2025, May 2, 2025, and April 29, 2025, respectively. With an average price target of $23 between Mizuho, Barclays, and JMP Securities, there's an implied 287.21% upside for Kura Oncology Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jan
3
Feb
1
Mar
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Mizuho
Barclays
JMP Securities
HC Wainwright & Co.
UBS

1calculated from analyst ratings

Analyst Ratings for Kura Oncology

Buy NowGet Alert
05/19/2025Buy Now405.05%Mizuho
Mara Goldstein56%
$32 → $30MaintainsOutperformGet Alert
05/02/2025Buy Now85.19%Barclays
Peter Lawson42%
$32 → $11MaintainsOverweightGet Alert
04/29/2025Buy Now371.38%JMP Securities
Reni Benjamin47%
$28 → $28ReiteratesMarket Outperform → Market OutperformGet Alert
04/28/2025Buy Now573.4%HC Wainwright & Co.
Joseph Pantginis46%
$40 → $40ReiteratesBuy → BuyGet Alert
03/06/2025Buy Now135.69%UBS
David Dai26%
$27 → $14MaintainsBuyGet Alert
02/27/2025Buy Now573.4%HC Wainwright & Co.
Joseph Pantginis46%
$40 → $40ReiteratesBuy → BuyGet Alert
02/06/2025Buy Now371.38%JMP Securities
Reni Benjamin47%
$28 → $28ReiteratesMarket Outperform → Market OutperformGet Alert
02/06/2025Buy Now506.06%Wedbush
Robert Driscoll44%
$34 → $36MaintainsOutperformGet Alert
02/06/2025Buy Now573.4%HC Wainwright & Co.
Joseph Pantginis46%
$37 → $40MaintainsBuyGet Alert
01/08/2025Buy Now68.35%Scotiabank
George Farmer39%
$18 → $10MaintainsSector PerformGet Alert
12/09/2024Buy NowCantor Fitzgerald
Li Watsek40%
ReiteratesOverweight → OverweightGet Alert
11/26/2024Buy NowCantor Fitzgerald
Li Watsek40%
Reiterates → OverweightGet Alert
11/22/2024Buy Now388.22%B of A Securities
Jason Zemansky72%
$36 → $29MaintainsBuyGet Alert
11/21/2024Buy NowTD Cowen
Phil Nadeau66%
Reiterates → BuyGet Alert
11/21/2024Buy Now371.38%Jefferies
Roger Song35%
$32 → $28MaintainsBuyGet Alert
11/21/2024Buy NowCantor Fitzgerald
Li Watsek40%
Reiterates → OverweightGet Alert
11/21/2024Buy Now522.9%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $37MaintainsBuyGet Alert
11/19/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
11/18/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
11/06/2024Buy NowCantor Fitzgerald
Li Watsek40%
Reiterates → OverweightGet Alert
11/06/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
10/24/2024Buy Now354.55%UBS
David Dai26%
→ $27Initiates → BuyGet Alert
10/24/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
10/14/2024Buy Now219.87%Stifel
Bradley Canino40%
$26 → $19DowngradeBuy → HoldGet Alert
09/09/2024Buy NowCantor Fitzgerald
Li Watsek40%
Reiterates → OverweightGet Alert
08/12/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
08/12/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
08/09/2024Buy NowCantor Fitzgerald
Li Watsek40%
Reiterates → OverweightGet Alert
08/09/2024Buy Now522.9%Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
08/09/2024Buy Now337.71%Stifel
Bradley Canino40%
$28 → $26MaintainsBuyGet Alert
06/24/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
06/18/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/16/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/14/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
05/06/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/03/2024Buy Now522.9%Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
05/03/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
04/22/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
03/06/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now371.38%Stifel
Bradley Canino40%
$27 → $28MaintainsBuyGet Alert
02/28/2024Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
$32 → $32ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now522.9%Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
01/31/2024Buy Now438.72%Mizuho
Mara Goldstein56%
$26 → $32MaintainsBuyGet Alert
01/31/2024Buy Now438.72%JMP Securities
Reni Benjamin47%
$22 → $32MaintainsMarket OutperformGet Alert
12/22/2023Buy Now337.71%Mizuho
Mara Goldstein56%
→ $26Initiates → BuyGet Alert
12/08/2023Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
→ $32ReiteratesBuy → BuyGet Alert
11/03/2023Buy Now522.9%Wedbush
Robert Driscoll44%
$40 → $37MaintainsOutperformGet Alert
10/18/2023Buy Now573.4%Wedbush
Robert Driscoll44%
→ $40ReiteratesOutperform → OutperformGet Alert
09/07/2023Buy Now405.05%Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now421.89%B of A Securities
Jason Zemansky72%
→ $31Initiates → BuyGet Alert
08/04/2023Buy Now304.04%Stifel
Bradley Canino40%
$25 → $24MaintainsBuyGet Alert
07/27/2023Buy Now76.77%Scotiabank
George Farmer39%
→ $10.5Initiates → Sector PerformGet Alert
07/21/2023Buy Now405.05%Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
06/13/2023Buy Now405.05%Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
06/13/2023Buy Now270.37%JMP Securities
Reni Benjamin47%
→ $22ReiteratesMarket Outperform → Market OutperformGet Alert
06/12/2023Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
→ $32ReiteratesBuy → BuyGet Alert
06/12/2023Buy Now320.88%Stifel
Bradley Canino40%
$24 → $25MaintainsBuyGet Alert
05/17/2023Buy Now421.89%BTIG
Justin Zelin40%
→ $31Initiates → BuyGet Alert
05/11/2023Buy Now337.71%Credit Suisse
Tiago Fauth44%
→ $26ReiteratesOutperform → OutperformGet Alert
05/11/2023Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
→ $32ReiteratesBuy → BuyGet Alert
04/17/2023Buy Now270.37%JMP Securities
Reni Benjamin47%
→ $22Reiterates → Market OutperformGet Alert
02/24/2023Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
→ $32Reiterates → BuyGet Alert
02/10/2023Buy Now438.72%HC Wainwright & Co.
Joseph Pantginis46%
→ $32Reiterates → BuyGet Alert
01/31/2023Buy Now320.88%Stifel
Bradley Canino40%
→ $25Initiates → BuyGet Alert
07/13/2022Buy Now388.22%Credit Suisse
Tiago Fauth44%
$27 → $29MaintainsOutperformGet Alert
07/12/2022Buy Now405.05%Cantor Fitzgerald
Li Watsek40%
→ $30Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Kura Oncology (KURA) stock?

A

The latest price target for Kura Oncology (NASDAQ:KURA) was reported by Mizuho on May 19, 2025. The analyst firm set a price target for $30.00 expecting KURA to rise to within 12 months (a possible 405.05% upside). 33 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kura Oncology (KURA)?

A

The latest analyst rating for Kura Oncology (NASDAQ:KURA) was provided by Mizuho, and Kura Oncology maintained their outperform rating.

Q

When was the last upgrade for Kura Oncology (KURA)?

A

There is no last upgrade for Kura Oncology

Q

When was the last downgrade for Kura Oncology (KURA)?

A

The last downgrade for Kura Oncology Inc happened on October 14, 2024 when Stifel changed their price target from $26 to $19 for Kura Oncology Inc.

Q

When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.

Q

Is the Analyst Rating Kura Oncology (KURA) correct?

A

While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a maintained with a price target of $32.00 to $30.00. The current price Kura Oncology (KURA) is trading at is $5.94, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch